L1 Capital Pty Ltd decreased its position in Anteris Technologies Global Corp. (NASDAQ:AVR – Free Report) by 58.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,812,000 shares of the company’s stock after selling 4,026,136 shares during the quarter. Anteris Technologies Global accounts for 0.7% of L1 Capital Pty Ltd’s portfolio, making the stock its 19th biggest holding. L1 Capital Pty Ltd owned approximately 0.07% of Anteris Technologies Global worth $14,032,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its stake in Anteris Technologies Global by 32.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock worth $6,379,000 after acquiring an additional 349,299 shares during the last quarter. UBS Group AG increased its stake in Anteris Technologies Global by 133.3% in the 4th quarter. UBS Group AG now owns 515,725 shares of the company’s stock worth $2,573,000 after acquiring an additional 294,695 shares during the last quarter. Duncan Williams Asset Management LLC bought a new stake in Anteris Technologies Global in the 4th quarter worth approximately $54,000. Macquarie Group Ltd. increased its stake in Anteris Technologies Global by 12,369.6% in the 4th quarter. Macquarie Group Ltd. now owns 33,668 shares of the company’s stock worth $168,000 after acquiring an additional 33,398 shares during the last quarter. Finally, Deutsche Bank AG increased its stake in Anteris Technologies Global by 8.1% in the 4th quarter. Deutsche Bank AG now owns 28,865 shares of the company’s stock worth $144,000 after acquiring an additional 2,171 shares during the last quarter.
Analysts Set New Price Targets
A number of analysts have issued reports on the company. Wells Fargo & Company assumed coverage on Anteris Technologies Global in a research note on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 price objective on the stock. Barclays lifted their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 price objective on shares of Anteris Technologies Global in a research note on Friday, March 27th. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Four analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.
Anteris Technologies Global Stock Performance
Shares of Anteris Technologies Global stock opened at $9.15 on Friday. The stock has a market cap of $890.66 million, a price-to-earnings ratio of -4.10 and a beta of 1.78. The stock has a 50 day moving average price of $7.23 and a 200-day moving average price of $6.06. Anteris Technologies Global Corp. has a one year low of $2.85 and a one year high of $10.14.
Anteris Technologies Global (NASDAQ:AVR – Get Free Report) last announced its earnings results on Tuesday, May 12th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The company had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same quarter last year, the firm posted ($0.61) EPS. Sell-side analysts predict that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current fiscal year.
Insider Activity at Anteris Technologies Global
In related news, Director Susan Elizabeth Knight bought 11,000 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was purchased at an average price of $9.29 per share, for a total transaction of $102,190.00. Following the acquisition, the director owned 11,000 shares in the company, valued at $102,190. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 4.50% of the company’s stock.
Anteris Technologies Global Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Featured Articles
- Five stocks we like better than Anteris Technologies Global
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Want to see what other hedge funds are holding AVR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anteris Technologies Global Corp. (NASDAQ:AVR – Free Report).
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
